AI assistant
Sending…
CONMED Corp — Director's Dealing 2023
Nov 9, 2023
31971_dirs_2023-11-09_5794115a-1de6-442b-a9f6-00dad35c7aa4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-11-07
Reporting Person: Peters Stanley W III (President AS and AET)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-07 | Common Stock | M | 1200 | $41.93 | Acquired | 1263 | Direct |
| 2023-11-07 | Common Stock | S | 1200 | $102.395 | Disposed | 63 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-11-07 | Options To Purchase Common Stock | $41.93 | M | 1200 | Disposed | 2027-03-01 | Common Stock (1200) | Direct |
Footnotes
F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
More from CONMED Corp
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18